TLR5 and inflammatory bowel disease: Moreover, TLR5 activation in an ex vivo model of IBD determined a decrease in epithelial barrier resistance and the altered expression of tight junction proteins (claudin-3, occludin and zonula occludens-1) compared with controls [47].